EarningsSQURPHARMA
SQURPHARMA Earnings Update
Announcement summary
- What happened
- SQURPHARMA published a corporate disclosure on 23 October 2019. Read the full announcement for details.
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
(Continuation news of SQURPHARMA): The Company has also reported Consolidated EPS of Tk. 16.03, Consolidated NAV per share of Tk. 86.03 and Consolidated NOCFPS of Tk. 15.71 for the year ended on June 30, 2019 as against Tk. 14.69, Tk. 73.28 and Tk. 12.55 respectively for the same period of the previous year. The Company also informed that i) Bonus shares has been recommended in view to utilize its retained amount as capital for business expansion. (cont.2)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616aceb25a6b000040058b1b
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.